Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cuthbertson

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Rheumatology|April 15, 2025
Frailty and Associated Outcomes in Patients With VasculitisSebastian E Sattui, John Stadler, Renee L Borchin, et al.
Diabetologia|November 19, 2024
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumabAlfonso Galderisi, Emily K Sims, Carmella Evans-Molina, et al.
Diabetes Care|September 11, 2009
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1Tihamer Orban, Jay M Sosenko, David Cuthbertson, et al.
Diabetes Care|June 16, 2012
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youthKendra Vehik, David Cuthbertson, David Boulware, et al.
Diabetes Care|November 15, 2007
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1Jay M Sosenko, Jeffrey P Krischer, Jerry P Palmer, et al.
Pediatric Diabetes|January 19, 2012
Growth differences between North American and European children at risk for type 1 diabetesAnita M Nucci, Dorothy J Becker, Suvi M Virtanen, et al.
Diabetes Care|June 3, 2009
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Lisa Rafkin-Mervis, et al.
Diabetes Care|April 28, 2005
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetesMaria J Redondo, Sunanda Babu, Adina Zeidler, et al.
Diabetologia|January 21, 2021
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at riskAnita M Nucci, Suvi M Virtanen, David Cuthbertson, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Rheumatology|April 15, 2025
Frailty and Associated Outcomes in Patients With VasculitisSebastian E Sattui, John Stadler, Renee L Borchin, et al.
Diabetologia|November 19, 2024
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumabAlfonso Galderisi, Emily K Sims, Carmella Evans-Molina, et al.
Diabetes Care|September 11, 2009
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1Tihamer Orban, Jay M Sosenko, David Cuthbertson, et al.
Diabetes Care|June 16, 2012
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youthKendra Vehik, David Cuthbertson, David Boulware, et al.
Diabetes Care|November 15, 2007
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1Jay M Sosenko, Jeffrey P Krischer, Jerry P Palmer, et al.
Pediatric Diabetes|January 19, 2012
Growth differences between North American and European children at risk for type 1 diabetesAnita M Nucci, Dorothy J Becker, Suvi M Virtanen, et al.
Diabetes Care|June 3, 2009
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Lisa Rafkin-Mervis, et al.
Diabetes Care|April 28, 2005
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetesMaria J Redondo, Sunanda Babu, Adina Zeidler, et al.
Diabetologia|January 21, 2021
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at riskAnita M Nucci, Suvi M Virtanen, David Cuthbertson, et al.
Pageof 15